On March 21, 2025, China’s Multimodal Trans-scale Biomedical Imaging Facility, a major national scientific infrastructure, received national acceptance in Beijing’s Huairou Science City.

After 12 years of planning, construction, and trials, this cutting-edge facility, led by Peking University, with partnership from the Institute of Biophysics of the Chinese Academy of Sciences and support from Harbin Institute of Technology and the University of Science and Technology of China, is poised to transform life sciences research and advance the diagnostics and treatment of major diseases.

With a total investment of 1.717 billion yuan, the facility spans 6.67 hectares and encompasses 72,000 square meters of research space, making it the largest single construction project in Peking University’s history.

Operated by the National Biomedical Imaging Center (NBIC), it integrates cutting-edge multimodal imaging technologies to visualize and analyze biological structures and functions across scales, from molecules to organs. The facility features four core platforms: a multimodal medical imaging platform, a multimodal in vivo cell imaging platform, a high-resolution molecular imaging platform, and a full-scale image data integration system. These are complemented by specialized infrastructure, including a model animal center, enhancing its research capabilities.

Positioned as a global hub for biomedical innovation, the facility is forging international partnerships with leading imaging platforms in the United States, the European Union, and beyond. These collaborations aim to accelerate breakthroughs in Chinese biomedical research and contribute significantly to global advancements in life sciences.

Embracing the concept of “digital life,” the facility drives large-scale, interdisciplinary research in foundational science and disease studies, with a focus on brain science, oncology, and neurodegenerative diseases. Now fully operational, it pioneers digital life paradigms and invites global researchers to leverage its cutting-edge resources and expertise, fostering open collaboration to shape the future of biomedical discovery.